Belsomra (suvorexant) has been available on the market since November 2014 [1][2].
When does Belsomra's patent expire?
The patents protecting Belsomra began to expire in 2027 [3]. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals, offering data on when generic versions of drugs may become available [4].
What is Belsomra used for?
Belsomra is a medication prescribed to treat insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults [5]. It works by blocking the activity of orexins, which are chemicals in the brain that promote wakefulness [6].
How does Belsomra compare to other sleep medications?
Unlike some other sleep medications that act on GABA receptors, Belsomra targets the orexin system, offering a different mechanism of action [5][6]. This difference may lead to a distinct side effect profile and efficacy for certain patients.
Who makes Belsomra?
Belsomra is manufactured by Merck & Co. [2].
What are potential side effects of Belsomra?
Common side effects reported for Belsomra include drowsiness, dizziness, and headache [7]. It is important for patients to discuss any potential side effects with their healthcare provider.
Can I get Belsomra without a prescription?
No, Belsomra is a prescription-only medication [5].
Are there generic versions of Belsomra available?
As of now, generic versions of Belsomra are not widely available due to ongoing patent protections. Once patent exclusivity ends, generic manufacturers may seek approval to market their versions [3][4].
Sources:
[1] https://www.drugpatentwatch.com/drug/belsomra
[2] https://www.drugs.com/history/belsomra.html
[3] https://www.drugpatentwatch.com/drug/suvorexant
[4] https://www.drugpatentwatch.com/
[5] https://www.belsomra.com/
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173099/
[7] https://www.webmd.com/drugs/2/drug-165107/belsomra-oral/details